BioMed X - AION Labs: Call for Application for Prediction of Clinical Trial Outcome in Biomarker-Stratified Cancer Patient Populations

[BioMed X Institute]

Dear Sir or Madam,   We are pleased to share with you the start of our third joint call for application with AION Labs in Israel entitled “Prediction of clinical trial outcome in biomarker-stratified cancer patient populations”. The winning scientists of this call and subsequent innovation boot camp will be invited to start their own fully funded AI company at our innovation lab in Rehovot, Israel with mentorship and support from our sponsors AstraZeneca, Merck, Pfizer, Teva, and Amazon Web Services. We would greatly appreciate if you could share this information within your network. For more information, please refer to our call announcement page at https://career.bio.mx/call/2022-AIL-C04 or our press release. Your thoughts and comments are always welcome. Best wishes, Yvonne Yvonne Stappenbeck VP HR & Operations BioMed X Institute Mail: y...@bio.mx Phone +49 6221 4261112

This email was sent to bmes....@gmail.com why did I get this?    unsubscribe from this list    update subscription preferences BioMed X Institute · Im Neuenheimer Feld 515 · Heidelberg 69120 · Germany